The largest database of trusted experimental protocols

6 protocols using mca rppgfsafk dnp oh

1

In Vitro Selection of IDE-Targeting Macrocyclic Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro selection of the DNA-templated library8 (link) used 20 µg His6-tagged mouse IDE immobilized on cobalt magnetic beads (Invitrogen). IDE inhibition was assayed using the fluorogenic peptide Mca-RPPGFSAFK(Dnp)-OH (R&D), confirmed using an anti-insulin antibody time-resolved FRET assay (Cysbio), and a LCMS assay for CGRP cleavage fragments in plasma9 (link). Macrocyclic inhibitors were synthesized by Fmoc-based solid-phase synthesis and purified by HPLC. LCMS quantitation of 6bK in biological samples was performed using 6bK synthesized with 13C6,15N2 lysine (Sigma-Aldrich).
Wild-type lean and DIO C57BL/6J age-matched male mice (Jackson Laboratories) were used at 14–16, and 24–26 weeks respectively (> 20 weeks of high-fat diet). Gcgr−/− and Ide−/− mice were fully backcrossed to the C57BL/6J line, bred from heterozygous mice, and used between 11 and 21 weeks. Animals were fasted overnight 14 h for all experiments, except for the insulin tolerance test, which required 5 h of fasting during the morning. Blood glucose was measured from tail nicks using AccuCheck (Aviva) meters. Trunk blood was obtained for plasma hormone measurements using the Multiplexed Mouse Metabolic Hormone panel (Milliplex, EMD Millipore) on a Luminex FlexMap 3D instrument.
+ Open protocol
+ Expand
2

Kinetic Analysis of NEP Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 20 μ assay was performed on low-volume black Costar 384-well plates at 25 C°. A working solution of 160 μM peptide substrate MCA-RPPGFSAFK(Dnp)-OH (R&D Systems) was prepared in 50 mM Tris-HCl pH7.8, 25 mM NaCl and 5 mM ZnCl2. 10 μl of NEP (R&D Systems) or NEP fusion polypeptide, diluted to 1, 2 or 4 nM in assay buffer, were transferred to plate. For determination of apparent KM values various concentrations of substrate (0.078–80 nM in 2-fold dilutions) were added and the enzyme reaction started. The fluorescence increase was monitored with excitation at 320 nm and emission at 405 nm on an Envision Reader. Hydrolysis rates and apparent KM values were calculated using XLFit® software (IDBS).
+ Open protocol
+ Expand
3

Enzymatic Inhibition Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified recombinant human enzymes were purchased from R&D Systems (Minneapolis, MN). The quenched peptide substrate for aminopeptidase N was Ala-AMC (Bachem 1410, Torrance, CA). The substrate for puromycin-sensitive aminopeptidase was Leu-AMC (Bachem 1240). The substrate for all remaining enzymes was MCA-RPPGFSAFK-Dnp-OH (R&D Systems). Each substrate was diluted to 100 μM in the assay buffer recommended for each enzyme by the supplier. To a black microtiter plate (Corning 3686), 5 μl of compound dilutions in assay buffer were aliquoted in triplicate. To these, 5 μl of diluted enzyme was added, followed by 10 μl of the quenched peptide substrate. The plates were incubated at 37°C until at least 10% substrate turnover or 5 μM product had formed. Fluorescence was measured using a Tecan Safire II (Excitation 320 nm/Emission 420 nm). Each plate included a standard curve of reaction product and positive (no enzyme) and negative (dimethyl sulfoxide vehicle) controls. Dose-response data were plotted and inhibition values (IC50) determined by linear regression analysis using GraphPad Prism (GraphPad Software, La Jolla, CA).
+ Open protocol
+ Expand
4

Purification and Characterization of Recombinant Human IDE

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression and purification of glutathione-S-transferase tagged human IDE (GST-IDE in pGEX-6p-1 vector, kindly provided by Dr. Malcolm Leissring of the University of California at Irvine) were accomplished following a protocol26 (link) provided by Dr. Leissring with some modifications. Expression of GST-IDE in Escherichia coli BL21 (DE3) CodonPlus RIL was induced with 50 μM IPTG overnight at 25 °C. The non-metalloprotease inhibitor phenylmethylsulfonyl fluoride was added prior to cracking the cells. GST-IDE was purified using a 5 mL GST Trap Fast Flow column on an ÄKTA Pure FPLC (GE Healthcare Life Sciences) and eluted with PBS containing 10 mM glutathione. After cleavage of the GST tag using GST PreScission protease, further purification of IDE was accomplished using a HiLoad 16/600 Superdex S-200 pg gel filtration column preequilibrated with PBS on the ÄKTA Pure FPLC. Purified protein concentration was determined by UV–vis spectroscopy using the molar extinction coefficient of IDE at 280 nm, ε280nm = 113570 M−1 cm−1.42 (link) Flash-frozen IDE aliquots containing 1% glycerol (v/v) were stored at −80 °C in PBS (pH 7.4). Activity of IDE was confirmed using insulin (Sigma-Aldrich) or the fluorogenic peptide Mca-RPPGFSAFK(Dnp)-OH (R&D Systems) as substrates.
+ Open protocol
+ Expand
5

Enzymatic Activity Assay for IDE and NEP

Check if the same lab product or an alternative is used in the 5 most similar protocols
10 μg of cell or brain lysates were mixed with 10 μM of the fluorogenic peptide Mca-RPPGFSAFK(Dnp)-OH (R&D Systems) in reaction buffer (100 mM Tris-Cl, pH 7.5, 50 mM NaCl, and 10 mM ZnCl2) and the fluorescent intensity of the cleaved fragments was monitored during 30 min at 37 °C with excitation at 320 nm and emission at 405 nm. Insulin (10 μM, Thermo Fisher Sci., RP-10908), a competitive substrate of IDE or thiorphan (40 μM, Santa Cruz Biotech., sc-201287), a potent inhibitor of NEP, was added to distinguish the specific enzyme activities. In both cases, we first determined the dose that achieves maximum substrate cleavage inhibition using 10 μg of lysate (Supplementary Fig. S1). IDE activity was defined as the activity sensitive to insulin inhibition and NEP activity was defined as the activity sensitive to thiorphan inhibition.
+ Open protocol
+ Expand
6

Quantitative SARS-CoV-2 RBD Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant proteins of human ACE2 extracellular enzymatic domain were purchased from R&D systems(933-ZN) and Sinobiological, Inc(10108-H08H). Recombinant proteins of SARS-CoV RBD (40150-V08B2) and SARS-CoV-2 RBD proteins (40592-V08H) were obtained from Sinobiological, Inc. Fluorogenic peptide substrates were obtained from R&D systems, where Mca-YVADAPK(Dnp)-OH (ES007) was used as an angiotensin II like substrate and Mca-RPPGFSAFK(Dnp)-OH(ES005) was a fluorogenic peptide derivative of Bradykinin according to manufacturer’s instruction. Non-fluorogenic bradykinin(BK, RPPGFSPFR), des-Arg9-bradykinin (desBK, RPPGFSPF) and angiotensin II (Ang II, DRVYIHPF) peptides were purchased from Genscript, Inc. Fluorogenic peptide Mca-Pro-Leu-OH (Bachem, M-1975) was used as calibration standard to obtain the molarity (pmol) to relative fluorescence unit (RFU) conversion factor on Synergy H1 fluorescent plate reader.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!